DJIA 16,943.88 24.29 0.14%
NASDAQ 4,525.88 -1.63 -0.04%
S&P 500 1,983.21 1.61 0.08%
market minute promo

Questcor Pharmaceuticals (NASDAQ: QCOR)

0.00 0.00 (0.00%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

QCOR 0.00 0.00%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open 0.00
Previous Close 0.00
Daily Range 0.00 - 0.00
52-Week Range 0.00 - 0.00
Market Cap 0.0000
P/E Ratio 0.00
Dividend (Yield) 1.20 (1.3%)
Ex-Dividend Date
Dividend Pay Date
06/27/14
07/08/14
Volume 0
Average Daily Volume 0
Current FY EPS 7.19

Sector

Healthcare

Industry

Drugs

Questcor Pharmaceuticals (QCOR) Description

A pharmaceutical company that focuses on novel therapeutics for the treatment of diseases and disorders of the central nervous system. Website: http://www.questcor.com/

News & Commentary

Why I'm Still Avoiding Questcor

A total of seven litigations against Questcor are currently underway. Two of them - the Retrophin litigation and USAO litigation - represent very serious threats to the H.P. Acthar business model.

Update: Questcor Shareholders Are The Net Gainers Of Acquisition Deal

Gulfmark Offshore (GFL) Now Added to S&P SmallCap 600 Index - Analyst Blog

Prem Watsa Buys 4 New Stocks

Retrophin CEO Under Fire for Twitter Faux Pas

Mallinckrodt Is Like Steak - Very Tasty

Paulson Bets Again On Mallinckrodt

Top Performing Funds Play Favorits

Questcor Seems To Lie By Omission To The SEC, Aetna National Medical Director Slams Acthar

Questcor Ate The Steak, Mallinckrodt Likely To Foot The Bill

Questcor (QCOR) Misses on Q2 Earnings, Beats on Revenues - Analyst Blog

See More QCOR News...

QCOR's Top Competitors

QCOR 0.00 (0.00%)
Current stock: QCOR
JNJ $102.99 (0.03%)
Current stock: JNJ
NVS $88.67 (0.05%)
Current stock: NVS
RHHBY $36.46 (-0.49%)
Current stock: RHHBY